Seed Co., Ltd. (7743) AI Stock Analysis

• Market Cap: ¥17.16B
• Dividend Yield: 2.65%
• Average Volume (3M): 68.49K
• Price to Earnings (P/E): 14.6
• Beta (1Y): 0.63
• Revenue Growth: 0.81%
• EPS Growth: -26.76%
• Country: JP
• Employees: 962
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Instruments & Supplies
• EPS (TTM): 2.47
• Shares Outstanding: 30,265,923
• 10 Day Avg. Volume: 58,390
• 30 Day Avg. Volume: 68,493
• PEG Ratio: -0.25
• Price to Book (P/B): 0.82
• Price to Sales (P/S): 0.44
• P/FCF Ratio: -8.65
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): 41.3
• Revenue Forecast (FY): ¥35.30B

• Rating: 52 Neutral
• Price Target: ¥552.00 ▼(-4.00% Downside)
• Action: Reiterated Date: 02/11/26
• Date: Action: Reiterated 02/11/26

The score is driven primarily by mixed fundamentals: solid revenue growth and healthy gross margin, but constrained by notable leverage and a deterioration to slightly negative TTM free cash flow. Technicals further weigh on the score as the stock trades below key moving averages with negative MACD and low RSI. Valuation is a relative positive, supported by a reasonable P/E and a ~2.7% dividend yield.

Positive Factors

Strong gross margin & revenue growth

High TTM gross margin (~44.8%) alongside revenue growth (~+5.9%) indicates durable product economics and relative pricing strength in core lens products. Sustained margins support reinvestment in R&D, marketing and margin-focused initiatives, underpinning long-term unit economics and resilience.

Positive operating cash flow

Operating cash flow of ~¥2.4B that covers net income demonstrates the core business generates real cash from operations. Persistent positive OCF supports working-capital needs, funds maintenance capex and dividends, and provides a buffer for debt servicing or cyclical weakness without immediate financing.

Niche vision-care product franchise

Seed’s focus on disposable and specialty contact lenses creates recurring consumable demand and niche product differentiation. Manufacturing expertise and regulatory experience in the medical/vision-care space raise barriers to entry and support stable demand and customer loyalty over time.

Negative Factors

Meaningful leverage

Debt-to-equity around 1.39 indicates meaningful leverage that constrains financial flexibility. Elevated debt increases interest burdens and refinancing exposure, reducing headroom for strategic investments and amplifying downside risk if demand or margins deteriorate over the coming months.

Thin and volatile profitability

EBIT margin near 6% and net margin ~4% reflect limited profitability cushions. Thin margins heighten sensitivity to input-cost inflation and pricing pressure, constraining ability to self-fund growth and making earnings outcomes more volatile absent sustained revenue expansion or margin improvement.

Negative trailing free cash flow

TTM free cash flow turning slightly negative (~-¥0.2B) after being strongly positive signals a material weakening in cash conversion. Negative FCF reduces capacity to deleverage, invest organically or sustain distributions, potentially necessitating external financing or operational adjustments.

Seed Co., Ltd. Business Overview & Revenue Model

Company Description

SEED Co.,Ltd. manufactures and supplies contact lenses, care products, spectacle frames, and other eye care products in Japan and internationally. The company offers SEED 1dayPure moisture daily disposable, SEED 1dayPure moisture multistage, SEED Eye coffret 1day UV, SEED 1dayPure EDOF, SEED PlusMode 1day Homme, and JILL STUART 1day UV contact lenses, as well as SEED 1dayPure moisture contact lenses for astigmatism. It also provides SEED 2weekPure moisture disposable contact lenses and SEED 2weekPure moisture multistage bifocal lenses, as well as SEED 2weekPure moisture contact lenses for astigmatism; SEED MonthlyFine UV and monthly color lens UV replacement contact lenses; rigid gas permeable contact lenses; and medical contact lenses. In addition, the company offers glass frames under the Vivid Moon, ViVi fleurs, and Plusmix brand names; and pharmaceutical products, such as Adeno Test AD, an adenovirus antigen detection agent, and other products for better vision. SEED Co., Ltd. was founded in 1957 and is headquartered in Tokyo, Japan.

How the Company Makes Money

Seed Co., Ltd. generates revenue primarily through the sale of seeds, which includes hybrid and GMO varieties designed for different crops such as maize, soybeans, and cotton. The company also earns income from licensing its seed technology and intellectual property to other agricultural businesses, expanding its market reach. Additionally, Seed Co. engages in research and development partnerships with agricultural institutions and universities to innovate and improve seed varieties, which can lead to new products and revenue streams. The company's extensive distribution network and strong relationships with farmers further bolster its sales, as it provides not only seeds but also agronomic support and services, enhancing customer loyalty and driving repeat business.

Seed Co., Ltd. Financial Statement Overview

Summary

Income statement is improving (TTM revenue +5.9%, gross margin ~44.8%) but profitability is still thin (EBIT margin ~6.0%, net margin ~4.1%) and has shown volatility versus prior periods. Balance sheet leverage is notable (debt-to-equity ~1.39), and cash flow is the main weak spot with TTM free cash flow slightly negative (~-¥0.2B) after being strongly positive in 2024.

Income Statement

TTM (Trailing-Twelve-Months) revenue grew ~5.9% with a solid gross margin (~44.8%), indicating healthy product economics. Profitability, however, is modest at the bottom line (net margin ~4.1%) and operating profit remains thin (EBIT margin ~6.0%), suggesting limited pricing power and/or a higher cost base. Results have improved markedly versus the 2023 loss year, but net income is still below the stronger 2024 level, pointing to some earnings volatility.

Balance Sheet

Leverage is meaningful with debt running above equity (TTM debt-to-equity ~1.39), which can constrain flexibility in a softer demand or margin environment. Equity has grown versus 2023 and return on equity has recovered to ~7.6% in TTM (positive and improving), but it remains moderate relative to the leverage being carried. Overall balance sheet is workable, though debt levels are a clear watch item.

Cash Flow

Cash generation has weakened: TTM operating cash flow is positive (~¥2.4B) but free cash flow is slightly negative (~-¥0.2B) after being strongly positive in 2024. The sharp decline in free cash flow (TTM growth -116%) suggests heavier investment and/or working-capital drag. While operating cash flow still covers net income, the swing to negative free cash flow reduces financial flexibility near-term.

Breakdown	TTM	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	33.57B	33.23B	32.40B	30.59B	28.84B	28.62B
Gross Profit	15.14B	14.63B	14.18B	11.62B	12.01B	12.41B
EBITDA	5.18B	5.05B	5.12B	2.83B	4.45B	4.55B
Net Income	1.17B	1.09B	1.96B	-316.09M	1.15B	1.13B
Balance Sheet
Total Assets	53.02B	51.76B	49.57B	40.01B	41.79B	41.26B
Cash, Cash Equivalents and Short-Term Investments	5.17B	7.12B	9.89B	4.94B	3.88B	3.96B
Total Debt	25.64B	28.12B	24.30B	20.97B	22.09B	22.93B
Total Liabilities	34.13B	33.38B	31.92B	27.87B	29.25B	29.61B
Stockholders Equity	18.58B	18.06B	17.36B	11.86B	12.26B	11.49B
Cash Flow
Free Cash Flow	-206.19M	-1.70B	2.19B	2.79B	2.15B	1.52B
Operating Cash Flow	2.43B	2.98B	6.02B	3.35B	3.27B	3.69B
Investing Cash Flow	-3.19B	-4.57B	-3.76B	-440.73M	-881.61M	-1.66B
Financing Cash Flow	-2.46B	-1.13B	2.64B	-1.82B	-2.42B	-1.73B

Seed Co., Ltd. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 575.00
• 50DMA: Negative
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7743, the sentiment is Positive. The current price of 575 is above the 20-day moving average (MA) of 552.00, above the 50-day MA of 568.60, and above the 200-day MA of 529.10, indicating a neutral trend. The MACD of -7.44 indicates Negative momentum. The RSI at 56.33 is Neutral, neither overbought nor oversold. The STOCH value of 94.84 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:7743.

Seed Co., Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
5889	79 Outperform	¥48.22B	11.41	―	3.22%	12.92%	29.48%
7980	75 Outperform	¥6.38B	9.12	―	1.93%	4.41%	-16.07%
7780	74 Outperform	¥144.55B	20.75	5.97%	1.78%	3.17%	7.07%
3046	65 Neutral	¥124.17B	14.65	28.56%	1.97%	17.13%	78.33%
7782	65 Neutral	¥2.98B	11.69	―	2.23%	12.03%	18.72%
7743	52 Neutral	¥17.16B	14.63	―	2.65%	0.81%	-26.76%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%

Seed Co., Ltd. Corporate Events

Seed Co. Posts Higher Nine-Month Profit and Confirms Full-Year Outlook

Seed Co., Ltd. reported consolidated net sales of ¥25.52 billion for the nine months ended December 31, 2025, up 1.3% year on year, with operating profit rising 2.2% to ¥1.29 billion and profit attributable to owners of parent increasing 9.8% to ¥905 million. Earnings per share climbed to ¥29.93, while total assets reached ¥53.02 billion and the capital adequacy ratio held steady at 35.0%, signaling a modest strengthening of its financial base.

The company kept its full-year forecast unchanged, projecting ¥37.0 billion in net sales, a 28.0% rise in operating profit to ¥2.0 billion, and an annual dividend of ¥15 per share, suggesting confidence in sustaining earnings momentum. Seed also reported significant changes in its consolidation scope, adding five subsidiaries including SEED CONTACT LENS (M) SDN. BHD and removing one European unit, indicating a continued strategic realignment of its overseas operations to support growth and profitability in key markets.

The most recent analyst rating on (JP:7743) stock is a Hold with a Yen642.00 price target. To see the full list of analyst forecasts on Seed Co., Ltd. stock, see the JP:7743 Stock Forecast page.

SEED Co., Ltd. Updates Management Strategies Amid Listing Compliance Efforts

SEED Co., Ltd. has updated its management strategies to address capital costs and stock prices, aiming to comply with listing maintenance standards by March 31, 2026. Failure to meet these standards could lead to delisting, prompting the company to prepare for a potential market segment change to ensure liquidity and sustainable growth.

The most recent analyst rating on (JP:7743) stock is a Hold with a Yen584.00 price target. To see the full list of analyst forecasts on Seed Co., Ltd. stock, see the JP:7743 Stock Forecast page.

SEED Co., Ltd. Secures Subsidy to Boost Contact Lens Production

SEED Co., Ltd. has been awarded a subsidy under the ‘Large-Scale Growth Investment Subsidy for Labor-Saving Measures to Increase Wages at Medium-Sized and Small Enterprises’ by the Ministry of Economy, Trade and Industry. The subsidy will support SEED’s plan to expand production capacity, specifically for new material contact lenses, and is expected to result in a 5.50% salary increase for employees and a 5.00% increase for officers by the fiscal year ending March 2031. The financial impact on the current fiscal year is expected to be minor, with production facilities becoming operational by March 2028.

The most recent analyst rating on (JP:7743) stock is a Hold with a Yen584.00 price target. To see the full list of analyst forecasts on Seed Co., Ltd. stock, see the JP:7743 Stock Forecast page.